Scarica l'app Stockscreener
1.76
0.00%
0.00
Dopo l'orario di chiusura:
1.79
0.03
+1.70%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CHRS Giù?
Forum
Previsione
Coherus Oncology Inc Borsa (CHRS) Ultime notizie
How The Coherus Oncology (CHRS) Narrative Is Evolving Around Clinical Catalysts And Valuation Risks - Yahoo Finance
Coherus BioSciences at TD Cowen Conference: Strategic Oncology Shift - Investing.com
CHRS: Strong oncology focus, robust pipeline, and accelerating LOQTORZI sales drive future growth - TradingView
CHRS: Rapid oncology transformation, strong LOQTORZI growth, and promising pipeline assets drive outlook - TradingView
Coherus Oncology, Inc. to Release 2025 Financial Results on March 9, 2026, with Conference Call to Follow - Quiver Quantitative
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 - GlobeNewswire
Coherus Oncology (CHRS) Projected to Post Quarterly Earnings on Monday - MarketBeat
CHRS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Phathom Pharmaceuticals, Inc. (PHAT) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Hepatocellular Carcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 90+ Key Companies | DelveInsight - StreetInsider
Hepatocellular Carcinoma Clinical Trial Pipeline Shows - openPR.com
Coherus Oncology (NASDAQ:CHRS) Stock Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Coherus Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire
Coherus: Downgrade To 'Hold' On Potential Advancement Of Anti-CCR8 CHS-114 (NASDAQ:CHRS) - Seeking Alpha
Coherus Oncology announces proposed public offering of common stock - MSN
How Recent Developments Are Rewriting The Story For Coherus Oncology (CHRS) - Yahoo Finance
Coherus closes $50.1 million public offering of common stock By Investing.com - Investing.com Australia
Coherus closes $50.1 million public offering of common stock - Investing.com India
Coherus Biosciences Completes $47 Million Equity Offering - TipRanks
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock - The Manila Times
Oncology biotech Coherus raises $50M for LOQTORZI and clinical programs - Stock Titan
Coherus Oncology (NASDAQ: CHRS) raises $47M through common stock offering - Stock Titan
More drugmakers are turning to cancer combos. Will it help patients live longer? - PharmaVoice
Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of "Hold" by Analysts - MarketBeat
Coherus Oncology prices $50.1 million public offering of common stock By Investing.com - Investing.com Canada
Coherus BioSciences stock falls after pricing $50.1 million share offering By Investing.com - Investing.com Australia
CHRS Should I Buy - Intellectia AI
CHRS Successfully Completes Joint Book-Running Offering - GuruFocus
Coherus Oncology prices stock offering to raise $50.1M - MSN
Latham & Watkins Advises Coherus Oncology on Public Offering of Common Stock - Latham & Watkins LLP
Coherus Oncology’s Stock Offering: Strategic Moves Unveiled - timothysykes.com
Coherus BioSciences stock falls after pricing $50.1 million share offering - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Coherus Oncology tumbles on $50 mln stock sale - TradingView
Coherus Prices $50.1 Mln Public Offering; Stock Plunges - RTTNews
Coherus Oncology (CHRS) Launches $50.1M Public Offering - GuruFocus
Coherus BioSciences Prices $50.1 Million Share Offering - marketscreener.com
Coherus BioSciences (CHRS) Announces Public Stock Offering - GuruFocus
Coherus Oncology prices $50.1 million public offering of common stock - Investing.com
Coherus Oncology Prices Public Offering at $1.75 per Share - Intellectia AI
Cancer-drug firm Coherus to raise $50M for LOQTORZI, clinical development - Stock Titan
Coherus Oncology announces pricing of public offering of common stock - marketscreener.com
Coherus Oncology Announces Pricing Of Public Offering Of Common Stock - TradingView
Press Release: Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock - 富途牛牛
Coherus Oncology tumbles on planned equity offering - TradingView
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock - The Manila Times
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):